Literature DB >> 33006737

Autoimmune haemolytic anaemia and antiphospholipid antibodies in paediatrics: a systematic review and meta-analysis.

Mira Merashli1, Alessia Arcaro2, Maria Graf3, Fabrizio Gentile2, Paul R J Ames4,5.   

Abstract

INTRODUCTION/
OBJECTIVE: The relationship between autoimmune haemolytic anaemia (AIHA) and antiphospholipid antibodies (aPL) has never been addressed via a meta-analysis in the paediatric age group. We evaluated the link between AIHA and aPL in childhood systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS).
METHODS: EMBASE and PubMed were screened from inception to May 2020 and Peto's odds ratio for rare events was employed for the between group comparisons.
RESULTS: The meta-analysis included 11 articles for a total of 575 children: the pooled prevalence of AIHA was greater in (1) IgG aCL-positive than IgG aCL-negative children (39.7% vs 20.9%, p = 0.005); (2) in APS-positive than APS-negative SLE children (36.8% vs 13.2%, p = 0.01); and (3) in SLE-related APS than in primary APS children (53% vs 16.2%, p = 0.008).
CONCLUSIONS: The pooled prevalence of AIHA is greatest in SLE with aPL/APS, low-moderate in SLE without aPL/APS, and lowest in primary APS. Key Points • Antiphospholipid antibodies strongly relate to autoimmune haemolytic anaemia. • Autoimmune haemolytic anaemia is more common in systemic lupus erythematosus with antiphospholipid antibodies.

Entities:  

Keywords:  Antiphospholipid syndrome; Autoimmune haemolytic anaemia; Lupus

Mesh:

Substances:

Year:  2020        PMID: 33006737     DOI: 10.1007/s10067-020-05436-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  6 in total

1.  Comparison among ACR1997, SLICC and the new EULAR/ACR classification criteria in childhood-onset systemic lupus erythematosus.

Authors:  Adriana Rodrigues Fonseca; Marta Cristine Felix Rodrigues; Flavio Roberto Sztajnbok; Marcelo Gerardin Poirot Land; Sheila Knupp Feitosa de Oliveira
Journal:  Adv Rheumatol       Date:  2019-05-15

2.  The role of anticardiolipin autoantibodies in the pathogenesis of autoimmune hemolytic anemia in systemic lupus erythematosus.

Authors:  Z Sthoeger; D Sthoeger; L Green; D Geltner
Journal:  J Rheumatol       Date:  1993-12       Impact factor: 4.666

3.  Anticardiolipin antibodies in pediatric systemic lupus erythematosus.

Authors:  A Ravelli; R Caporali; G Di Fuccia; L Zonta; C Montecucco; A Martini
Journal:  Arch Pediatr Adolesc Med       Date:  1994-04

4.  Antiphospholipid antibodies in pediatric systemic lupus erythematosus.

Authors:  D E Seaman; A V Londino; C K Kwoh; T A Medsger; S Manzi
Journal:  Pediatrics       Date:  1995-12       Impact factor: 7.124

Review 5.  Antiphospholipid Antibodies and Autoimmune Haemolytic Anaemia: A Systematic Review and Meta-Analysis.

Authors:  Paul R J Ames; Mira Merashli; Tommaso Bucci; Daniele Pastori; Pasquale Pignatelli; Alessia Arcaro; Fabrizio Gentile
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

Review 6.  Differences in clinical features observed between childhood-onset versus adult-onset systemic lupus erythematosus: A systematic review and meta-analysis.

Authors:  Pravesh Kumar Bundhun; Alka Kumari; Feng Huang
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

  6 in total
  1 in total

Review 1.  Managing Antiphospholipid Syndrome in Children and Adolescents: Current and Future Prospects.

Authors:  Aline Garcia Islabão; Vitor Cavalcanti Trindade; Licia Maria Henrique da Mota; Danieli Castro Oliveira Andrade; Clovis Artur Silva
Journal:  Paediatr Drugs       Date:  2021-12-13       Impact factor: 3.022

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.